All Articles tagged Botanical drugs

• Perspective, Opinion, Commentary
  April 23, 2025 PDT
  A New Pathway: Botanical Drugs and the FDA
  Andrea Cespedes ZablahPeter Lio

  A long-overlooked class of medicines—botanical drugs—may finally gain traction in the U.S., as scientists and the FDA forge new pathways to bring plant-based therapies to mainstream medicine.

  Abstract